Context Therapeutics Inc. (CNTX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 4.07K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | -4.07K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 9.34M | 13.8M | 10.61M | 9.76M | 5.53M | 4.31M | 18.7M | 3.09M | 3.82M | 6.93M | 6.18M | 5.29M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 2.33M | 1.96M | 1.89M | 1.93M | 2.07M | 1.79M | 1.88M | 1.7M | 1.85M | 1.63M | 1.7M | 1.83M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 7.02M | 11.84M | 8.72M | 7.83M | 3.46M | 2.52M | 16.83M | 1.38M | 1.97M | 5.3M | 4.49M | 3.46M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.34M | -13.8M | -10.61M | -9.76M | -5.53M | -4.31M | -18.7M | -3.09M | -3.82M | -6.93M | -6.18M | -5.29M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -68.99% | -220.26% | 43.26% | -215.95% | -44.61% | 37.83% | -202.59% | 41.64% | 42.65% | -78.58% | -52.68% | -32.05% |
| EBITDA | -9.34M | -13.8M | -10.61M | -9.75M | -5.53M | -4.31M | -18.7M | -3.09M | -3.82M | -6.93M | -6.18M | -5.29M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -69.12% | -220.39% | 43.28% | -216.08% | -44.6% | 37.85% | -202.69% | 41.65% | 42.66% | -78.66% | -52.72% | -32.07% |
| D&A (Non-Cash Add-back) | 0 | 4.07K | 4.07K | 4.07K | 4.05K | 2.93K | 2.81K | 2.57K | 2.57K | 2.57K | 3.09K | 3.19K |
| EBIT | 0 | -13.8M | -9.69M | -9.76M | -5.53M | -4.31M | -18.7M | -3.09M | -3.82M | -6.93M | -6.18M | -5.29M |
| Net Interest Income | 0 | 682.48K | 833.77K | 903.77K | 958.52K | 964.04K | 1.24M | 840.15K | 152.35K | 224.72K | 290.44K | 293.27K |
| Interest Income | 520.14K | 682.48K | 833.77K | 903.77K | 958.52K | 964.04K | 1.24M | 840.15K | 152.35K | 224.72K | 290.44K | 293.27K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 663.23K | 779.04K | 917.24K | 930.85K | 951.88K | 967.51K | 1.24M | 834.04K | 155.7K | 163.32K | 305.81K | 281.05K |
| Pretax Income | -8.68M | -13.03M | -9.69M | -8.83M | -4.58M | -3.34M | -17.46M | -2.25M | -3.67M | -6.77M | -5.87M | -5.01M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -8.68M | -13.03M | -9.69M | -8.83M | -4.58M | -3.34M | -17.46M | -2.25M | -3.67M | -6.77M | -5.87M | -5.01M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -89.65% | -289.65% | 44.48% | -291.55% | -24.8% | 50.62% | -197.21% | 55.01% | 41.86% | -90.34% | -52.42% | -25.71% |
| Net Income (Continuing) | -8.68M | -13.03M | -9.69M | -8.83M | -4.58M | -3.34M | -17.46M | -2.25M | -3.67M | -6.77M | -5.87M | -5.01M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.09 | -0.14 | -0.10 | -0.09 | -0.05 | -0.06 | -0.22 | -0.04 | -0.23 | -0.42 | -0.37 | -0.31 |
| EPS Growth % | -80% | -144.76% | 54.55% | -126.1% | 78.26% | 86.38% | 40.54% | 86.77% | 42.5% | -88.52% | -54.17% | -24% |
| EPS (Basic) | -0.09 | -0.14 | -0.10 | -0.09 | -0.05 | -0.06 | -0.22 | -0.04 | -0.23 | -0.42 | -0.37 | -0.31 |
| Diluted Shares Outstanding | 95.18M | 91.88M | 95.19M | 95.19M | 95.19M | 58.42M | 80.48M | 54.96M | 15.97M | 15.97M | 15.97M | 15.97M |
| Basic Shares Outstanding | 95.18M | 91.88M | 95.19M | 95.19M | 95.19M | 58.42M | 80.48M | 54.96M | 15.97M | 15.97M | 15.97M | 15.97M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |